Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Net Income: 2011-2024

Historic Net Income for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $421,000.

  • Mimedx Group's Net Income rose 7617.97% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year increase of 1464.25%. This contributed to the annual value of $421,000 for FY2024, which is 104.57% up from last year.
  • Mimedx Group's Net Income amounted to $421,000 in FY2024, which was up 104.57% from -$9.2 million recorded in FY2023.
  • Mimedx Group's Net Income's 5-year high stood at $2.0 million during FY2021, with a 5-year trough of -$49.3 million in FY2020.
  • Its 3-year average for Net Income is -$6.3 million, with a median of -$9.2 million in 2023.
  • As far as peak fluctuations go, Mimedx Group's Net Income crashed by 608.13% in 2022, and later spiked by 104.57% in 2024.
  • Mimedx Group's Net Income (Yearly) stood at -$49.3 million in 2020, then skyrocketed by 104.09% to $2.0 million in 2021, then plummeted by 608.13% to -$10.2 million in 2022, then grew by 10.08% to -$9.2 million in 2023, then soared by 104.57% to $421,000 in 2024.